1. Distinct expression patterns of VEGFR 1-3 in gastroenteropancreatic neuroendocrine neoplasms: supporting clinical relevance, but not a prognostic factor;Bösch;J Clin Med,2020
2. VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis;Silva;Int J Cancer,2011
3. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors;Raymond;N Engl J Med,2011
4. Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study;Xu;Lancet Oncol,2020
5. Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study;Xu;Lancet Oncol,2020